StonvexLoading…
StonvexStonvexStonvexCore line items from NEPH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $5.21M | $18.79M | $14.06M | $9.30M |
Operating Income | $97.00K | $1.15M | $1.13M | $814.00K |
Net Income | $140.00K | $1.19M | $1.13M | $237.00K |
EPS (Diluted) | $0.01 | $0.11 | $0.10 | $0.07 |
Total Assets | $13.79M | $13.64M | $13.25M | $12.24M |
Total Liabilities | $3.09M | $3.44M | $3.24M | $2.64M |
Cash & Equivalents | $4.02M | $5.40M | $5.17M | $5.07M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 10.84M | 10.64M | 10.63M | 10.60M |